These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 26382220)

  • 21. Risk of genitourinary malignancy in patients that receive anticoagulant or antiplatelet therapy.
    Rysankova K; Vrtkova A; Viktoria MG; Vesela A; Krhut J
    Bratisl Lek Listy; 2023; 124(10):738-741. PubMed ID: 37789788
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of the time interval between diagnosis of muscle-invasive bladder cancer and radical cystectomy on staging and survival: A Netherlands Cancer Registry analysis.
    Bruins HM; Aben KK; Arends TJ; van der Heijden AG; Witjes AJ
    Urol Oncol; 2016 Apr; 34(4):166.e1-6. PubMed ID: 26705102
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hematuria as a Marker of Occult Urinary Tract Cancer: Advice for High-Value Care From the American College of Physicians.
    Nielsen M; Qaseem A;
    Ann Intern Med; 2016 Apr; 164(7):488-97. PubMed ID: 26810935
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Heparin as bridging anticoagulant and antiplatelet therapy during the perioperative period].
    Matsuoka T; Inoue K; Mizuno K; Kita Y; Nakanishi S; Asai S; Taoka R; Soda T; Terai A
    Hinyokika Kiyo; 2012 May; 58(5):223-6. PubMed ID: 22767274
    [TBL] [Abstract][Full Text] [Related]  

  • 25. NMP22: a sensitive, cost-effective test in patients at risk for bladder cancer.
    Zippe C; Pandrangi L; Potts JM; Kursh E; Novick A; Agarwal A
    Anticancer Res; 1999; 19(4A):2621-3. PubMed ID: 10470205
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of a multitarget fluorescence in situ hybridization assay to diagnose bladder cancer in patients with hematuria.
    Sarosdy MF; Kahn PR; Ziffer MD; Love WR; Barkin J; Abara EO; Jansz K; Bridge JA; Johansson SL; Persons DL; Gibson JS
    J Urol; 2006 Jul; 176(1):44-7. PubMed ID: 16753364
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of bladder cancer outcome in men undergoing hematuria home screening versus those with standard clinical presentations.
    Messing EM; Young TB; Hunt VB; Gilchrist KW; Newton MA; Bram LL; Hisgen WJ; Greenberg EB; Kuglitsch ME; Wegenke JD
    Urology; 1995 Mar; 45(3):387-96; discussion 396-7. PubMed ID: 7879333
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term outcome of hematuria home screening for bladder cancer in men.
    Messing EM; Madeb R; Young T; Gilchrist KW; Bram L; Greenberg EB; Wegenke JD; Stephenson L; Gee J; Feng C
    Cancer; 2006 Nov; 107(9):2173-9. PubMed ID: 17029275
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical predictors in the use of finasteride for control of gross hematuria due to benign prostatic hyperplasia.
    Kearney MC; Bingham J; Bergland R; Meade-D'Alisera P; Puchner PJ
    J Urol; 2002 Jun; 167(6):2489-91. PubMed ID: 11992064
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prospective external validation of a bladder cancer detection model.
    Lotan Y; Svatek RS; Krabbe LM; Xylinas E; Klatte T; Shariat SF
    J Urol; 2014 Nov; 192(5):1343-8. PubMed ID: 24859442
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk factors for delayed hematuria following photoselective vaporization of the prostate.
    Jackson RE; Casanova NF; Wallner LP; Dunn RL; Hedgepeth RC; Faerber GJ; Wei JT
    J Urol; 2013 Sep; 190(3):903-8. PubMed ID: 23538242
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outcomes associated with combined antiplatelet and anticoagulant therapy.
    Johnson SG; Rogers K; Delate T; Witt DM
    Chest; 2008 Apr; 133(4):948-54. PubMed ID: 18198244
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Can hematuria be a predictor as well as a symptom or sign of bladder cancer?
    Friedman GD; Carroll PR; Cattolica EV; Hiatt RA
    Cancer Epidemiol Biomarkers Prev; 1996 Dec; 5(12):993-6. PubMed ID: 8959322
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of an Epigenetic Profile for the Detection of Bladder Cancer in Patients with Hematuria.
    van Kessel KE; Van Neste L; Lurkin I; Zwarthoff EC; Van Criekinge W
    J Urol; 2016 Mar; 195(3):601-7. PubMed ID: 26327355
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adverse reactions related to treatment compliance during BCG maintenance therapy for non-muscle-invasive bladder cancer.
    Miyazaki J; Hinotsu S; Ishizuka N; Naito S; Ozono S; Akaza H; Nishiyama H
    Jpn J Clin Oncol; 2013 Aug; 43(8):827-34. PubMed ID: 23858038
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ten-Year Experience of Vascular Surgeon Management of Iatrogenic Pseudoaneurysms: Do Anticoagulant and/or Antiplatelet Medications Matter?
    Stone PA; Martinez M; Thompson SN; Masinter D; Campbell JE; Campbell Ii JR; AbuRahma AF
    Ann Vasc Surg; 2016 Jan; 30():45-51. PubMed ID: 26256702
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Heavy Cigarette Smoking and Aggressive Bladder Cancer at Initial Presentation.
    Pietzak EJ; Mucksavage P; Guzzo TJ; Malkowicz SB
    Urology; 2015 Nov; 86(5):968-72. PubMed ID: 26190088
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bladder cancer in Spain 2011: population based study.
    Miñana B; Cózar JM; Palou J; Unda Urzaiz M; Medina-Lopez RA; Subirá Ríos J; de la Rosa-Kehrmann F; Chantada-Abal V; Lozano F; Ribal MJ; Rodríguez Fernández E; Castiñeiras Fernández J; Concepción Masip T; Requena-Tapia MJ; Moreno-Sierra J; Hevia M; Gómez Rodríguez A; Martínez-Ballesteros C; Ramos M; Amón Sesmero JH; Pizá Reus P; Bohorquez Barrientos A; Rioja Sanz C; Gomez-Pascual JA; Hidalgo Zabala E; Parra Escobar JL; Serrano O
    J Urol; 2014 Feb; 191(2):323-8. PubMed ID: 23994371
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oral anticoagulant and antiplatelet therapy and peripheral arterial disease.
    ; Anand S; Yusuf S; Xie C; Pogue J; Eikelboom J; Budaj A; Sussex B; Liu L; Guzman R; Cina C; Crowell R; Keltai M; Gosselin G
    N Engl J Med; 2007 Jul; 357(3):217-27. PubMed ID: 17634457
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combined anticoagulant-antiplatelet use and major bleeding events in elderly atrial fibrillation patients.
    Shireman TI; Howard PA; Kresowik TF; Ellerbeck EF
    Stroke; 2004 Oct; 35(10):2362-7. PubMed ID: 15331796
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.